PAM
NTUS

Panagora Asset Management’s Natus Medical Inc NTUS Stock Holding History

Panagora Asset Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-139,692
Closed -$3.67M – 1639
2022
Q1 		$3.67M Buy
139,692
+50,940
+57% +$1.24M 0.02% 494
2021
Q4 		$2.11M Buy
88,752
+10,083
+13% +$249K 0.01% 629
2021
Q3 		$1.97M Buy
78,669
+22,188
+39% +$565K 0.01% 690
2021
Q2 		$1.47M Buy
56,481
+23,397
+71% +$637K 0.01% 821
2021
Q1 		$847K Buy
33,084
+29,925
+947% +$767K ﹤0.01% 1088
2020
Q4 		$63K Sell
3,159
-1,035
-25% -$20.3K ﹤0.01% 2000
2020
Q3 		$72K Sell
4,194
-18,249
-81% -$345K ﹤0.01% 1933
2020
Q2 		$490K Buy
22,443
+18,249
+435% +$418K ﹤0.01% 1208
2020
Q1 		$97K Buy
4,194
+1,035
+33% +$30.1K ﹤0.01% 1706
2019
Q4 		$104K Buy
+3,159
New +$101K ﹤0.01% 1794
2017
Q3 		– Sell
-13,824
Closed -$515K – 2561
2017
Q2 		$515K Sell
13,824
-198,200
-93% -$7.16M ﹤0.01% 1342
2017
Q1 		$8.32M Buy
212,024
+28,729
+16% +$1.08M 0.03% 464
2016
Q4 		$6.38M Buy
183,295
+57,376
+46% +$2.25M 0.03% 493
2016
Q3 		$4.95M Buy
125,919
+20,106
+19% +$802K 0.02% 554
2016
Q2 		$4M Sell
105,813
-1,428
-1% -$47.8K 0.02% 629
2016
Q1 		$4.12M Sell
107,241
-56,765
-35% -$2.11M 0.02% 634
2015
Q4 		$7.88M Buy
164,006
+789
+0.5% +$36.5K 0.04% 427
2015
Q3 		$6.44M Sell
163,217
-12,996
-7% -$552K 0.03% 436
2015
Q2 		$7.5M Buy
176,213
+47,248
+37% +$1.88M 0.04% 418
2015
Q1 		$5.09M Sell
128,965
-11,251
-8% -$415K 0.03% 494
2014
Q4 		$5.05M Buy
140,216
+9,676
+7% +$325K 0.03% 463
2014
Q3 		$3.85M Buy
130,540
+8,765
+7% +$242K 0.02% 559
2014
Q2 		$3.06M Buy
121,775
+23,461
+24% +$580K 0.01% 678
2014
Q1 		$2.54M Buy
98,314
+22,327
+29% +$563K 0.01% 778
2013
Q4 		$1.71M Buy
75,987
+35,611
+88% +$688K 0.01% 941
2013
Q3 		$572K Buy
40,376
+6,878
+21% +$92K ﹤0.01% 1322
2013
Q2 		$457K Buy
+33,498
New +$456K ﹤0.01% 1345

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Panagora Asset Management's NTUS Position: Q2 2022 in Review

Panagora Asset Management sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 139,692 shares — an estimated $3.67M sold.

Panagora Asset Management first reported a position in NTUS in Q2 2013 and held it in 27 quarters. The position peaked at $8.32M in Q1 2017. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.

  • Panagora Asset Management reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Panagora Asset Management sold 139,692 Natus Medical Inc shares in Q2 2022, an estimated $3.67M.
  • Panagora Asset Management first reported a position in Natus Medical Inc in Q2 2013 and held it in 27 quarters.
  • Panagora Asset Management's Natus Medical Inc position peaked at $8.32M in Q1 2017.
  • 186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.

Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.